Medicare Enrolled

Dr. Ranjan Dahal, MD

Interventional Cardiology · Longview, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
709 HOLLYBROOK DR STE 2301, Longview, TX 75605
3302538195
In practice since 2012 (13 years)
NPI: 1194070482 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dahal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dahal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dahal

Dr. Ranjan Dahal is an interventional cardiology in Longview, TX, with 13 years in practice. Based on federal Medicare data, Dr. Dahal performed 512 Medicare services across 411 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dahal received a total of $3,911 from 26 pharmaceutical and/or device companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dahal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ 512 Medicare services$ $3,911 industry payments

Medicare Practice Summary

Medicare Utilization ↗
512
Medicare services
Bottom 11% in TX for interventional cardiology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
411
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)98$94$287
Regadenoson injection (Lexiscan) for heart stress test76$28$152
Electrocardiogram (EKG), 12-lead56$11$45
New patient office visit (45-59 min)45$125$439
Hospital follow-up visit, moderate complexity34$61$196
Echocardiogram, transthoracic32$144$600
Office visit, established patient (20-29 min)29$68$195
Technetium tc-99m tetrofosmin, diagnostic, per study dose22$90$1,631
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician21$46$203
Nuclear medicine studies of heart muscle at rest and with stress and spect20$321$1,273
EKG interpretation and report19$6$23
Cardiac catheterization18$182$819
Heart muscle strain imaging16$28$107
New patient office visit (30-44 min)14$79$288
Initial hospital admission, moderate complexity12$100$371
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.8% high complexity
26.0% medium
64.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,911
Total received (2019-2024)
Avg $652/year across 6 years
Bottom 28% in TX for interventional cardiology
26
Companies
113
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,911 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$776
2023
$963
2022
$1,333
2021
$698
2020
$102
2019
$39

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,090
Abbott Laboratories
$587
Inari Medical, Inc.
$293
E.R. Squibb & Sons, L.L.C.
$283
Novartis Pharmaceuticals Corporation
$222
ABIOMED
$199
Shockwave Medical, Inc
$180
Merck Sharp & Dohme LLC
$131
Edwards Lifesciences Corporation
$113
Alnylam Pharmaceuticals Inc.
$108
Medtronic, Inc.
$104
W. L. Gore & Associates, Inc.
$94
PFIZER INC.
$86
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$73
Philips Electronics North America Corporation
$66
iRhythm Technologies, Inc.
$50
Janssen Pharmaceuticals, Inc
$39
Novo Nordisk Inc
$35
CARDIVA MEDICAL, INC.
$33
ATRICURE, INC.
$28
Cardiovascular Systems Inc.
$19
Amgen Inc.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
Merck Sharp & Dohme Corporation
$15
Lexicon Pharmaceuticals, Inc.
$14
AstraZeneca Pharmaceuticals LP
$12
Top 3 companies account for 50.4% of total payments
Associated products mentioned in payments ›
(9266) ELCA · (9267) AngioSculpt CV RX · BRILINTA · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CardioMEMS HF System · DIAMONDBACK CORONARY · Diamondback Coronary · ELIQUIS · ENTRESTO · EXCLUDER Conformable AAA Endoprosthesis with Active Control · FLOWTRIEVER CATHETER · GORE CARDIOFORM Septal Occluder · GORE DRYSEAL FLEX Introducer Sheath · GORE EXCLUDER Iliac Branch Endoprosthesis · General - Therapies · HAWKONE · HeartMate 3 Left Ventricular Assist Device · Impella · Inpefa · LEQVIO · LifeVest · ONPATTRO · Ozempic · Repatha · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY ABLATION SYSTEM · VERQUVO · WATCHMAN · XARELTO · XIFAXAN · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $764 per 100 Medicare services performed
Looking for a interventional cardiology in Longview?
Compare interventional cardiologys in the Longview area by procedure volume, costs, and industry payment transparency.
Browse interventional cardiologys nearby

Geographic Context

Interventional Cardiologys within 10 mi
8
Per 100K population
6.4
County median income
$64,809
Nearest hospital
LONGVIEW REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dahal is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Dahal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dahal performed 98 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dahal receive payments from pharmaceutical companies?
Yes. Dr. Dahal received a total of $3,911 from 26 companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dahal's costs compare to other interventional cardiologys in Longview?
Dr. Dahal's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dahal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →